Immunotherapeutic Strategies for COVID-19

A tétel rövid nézete
dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorTang, Shao Yu
dc.contributor.departmentDE--Gyógyszerésztudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2021-09-16T11:24:35Z
dc.date.available2021-09-16T11:24:35Z
dc.date.created2021-05-09
dc.description.abstractThe emerging outbreak of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel pathogen that was first identified in Wuhan, China in December 2019. COVID‐19 has been declared as a global pandemic due to its high transmissibility and continuing increased mortality. The urgent demand of effective treatments to control the current pandemic raised intense attention internationally and are being investigated vigorously all around the world. This thesis outlines the basic virology, clinical presentation of SARS-CoV-2, and an emphasis on immunopathogenesis and the potential Immunotherapies of the COVID‐19. These include various immunomodulators which stimulate or suppress the dysregulated immune system, passive immunization which provide immediate immune protection from convalescent plasma, IVIG or SARS‐CoV‐2‐specific monoclonal antibodies, active immunization by vaccines of different platforms which stimulate the host body to produce sufficient immunity against the virus, and other prospective immunotherapeutic approach such as cell therapy.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent58hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/321804
dc.language.isoenhu_HU
dc.subjectCOVID-19hu_HU
dc.subjectSARS-CoV-2
dc.subjectimmunopathogenesis
dc.subjectimmunotherapy
dc.subjectCOVID-19 vaccines
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleImmunotherapeutic Strategies for COVID-19hu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)